Abraham Rubinstein
Impact in
- Pharmaceutical Science top 0.1%
- Advanced Drug Delivery Systems
- Drug Solubulity and Delivery Systems
- Molecular Medicine top 1%
- Hydrogels: synthesis, properties, applications
Papers in
-
- Glycosylation and Glycoproteins Research 8
-
- Drug Solubulity and Delivery Systems 18
- Advanced Drug Delivery Systems 17
- Co-authors
- Morris Srebnik (18 shared papers)Reem Smoum (8 shared papers)Yechezkel Barenholz (10 shared papers)Boaz Tirosh (8 shared papers)Irit Gliko-Kabir (5 shared papers)Aviram Nissan (10 shared papers)Valery M. Dembitsky (1 shared paper)Amnon Sintov (5 shared papers)
- Journals
- Pharmaceutical Research (12 papers)Journal of Controlled Release (10 papers)International Journal of Pharmaceutics (10 papers)Journal of Pharmaceutical Sciences (8 papers)Molecular Pharmaceutics (4 papers)
- Partner nations
- IsraelUnited StatesRussia
In The Last Decade
Abraham Rubinstein
112 papers receiving 4.2k citations
Peers
Comparison fields: 5 of 143
- Pharmaceutical Science 1.3k
- Molecular Medicine 392
- Gastroenterology 342
- Biomaterials 687
- Food Science 521
Countries citing papers authored by Abraham Rubinstein
This map shows the geographic impact of Abraham Rubinstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abraham Rubinstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abraham Rubinstein more than expected).
Fields of papers citing papers by Abraham Rubinstein
This network shows the impact of papers produced by Abraham Rubinstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abraham Rubinstein. The network helps show where Abraham Rubinstein may publish in the future.
Co-authors
The 25 scholars most cited alongside Abraham Rubinstein, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 113 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 370 | |
| 2 | 1993 | 201 | |
| 3 | 1984 | 146 | |
| 4 | 1995 | 142 | |
| 5 | 2004 | 139 | |
| 6 | 2009 | 137 | |
| 7 | 1990 | 130 | |
| 8 | 1985 | 115 | |
| 9 | 2000 | 112 | |
| 10 | 1992 | 100 | |
| 11 | 2000 | 93 | |
| 12 | 2013 | 92 | |
| 13 | 2007 | 91 | |
| 14 | 2003 | 90 | |
| 15 | 1992 | 86 | |
| 16 | 1997 | 86 | |
| 17 | 1998 | 83 | |
| 18 | 2012 | 78 | |
| 19 | 2000 | 72 | |
| 20 | 2006 | 69 |
About Abraham Rubinstein
Abraham Rubinstein is a scholar working on Molecular Biology, Pharmaceutical Science, Organic Chemistry, Oncology and Nutrition and Dietetics, having authored 113 papers that have together received 4.4k indexed citations. Recurring topics across this work include Drug Solubulity and Delivery Systems (18 papers), Advanced Drug Delivery Systems (17 papers), Nanoparticle-Based Drug Delivery (10 papers), Polysaccharides Composition and Applications (8 papers), Pharmaceutical studies and practices (8 papers), Glycosylation and Glycoproteins Research (8 papers), Vitamin C and Antioxidants Research (8 papers) and Pharmacological Effects and Toxicity Studies (7 papers). The work is most often cited by research in Pharmaceutical Science (1.3k citations), Molecular Medicine (392 citations), Gastroenterology (342 citations), Biomaterials (687 citations) and Food Science (521 citations). Abraham Rubinstein has collaborated with scholars based in Israel, United States and Russia. Frequent co-authors include Morris Srebnik, Reem Smoum, Yechezkel Barenholz, Boaz Tirosh, Irit Gliko-Kabir, Aviram Nissan, Valery M. Dembitsky, Amnon Sintov, Boris Yagen and Adel Penhasi. Their work appears in journals such as Pharmaceutical Research, Journal of Controlled Release, International Journal of Pharmaceutics, Journal of Pharmaceutical Sciences and Molecular Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.